Home
Natural Products
Hot Products
Screening Libs
Serial Compounds
Bioactive
About Us
Plant Catalog
Use Citation
Contact Us
How to Order
Delivery time
Hot Products
Gypenoside LI
Catalog No: CFN91853
Gypenoside LI possesses inhibitory effect on the growth of cancer cells, it induces G2/M arrest.
Gypenoside XIII
Catalog No: CFN95239
Reference standards.
Gypenoside XLIX
Catalog No: CFN99717
Gypenoside XLIX, a naturally occurring gynosaponin, inhibits NF-kappaB activation via a PPAR-alpha-dependent pathway, it may treat inflammatory and cardiovascular diseases, including atherosclerosis.
Gypenoside XLVI
Catalog No: CFN93372
Gypenoside XLVI shows strong cytotoxic activity against A549 cells, with the IC50 values of 52.63±8.31 ug/ml.
Gypenoside XVII
Catalog No: CFN90193
Gypenoside XVII confers protection against Aβ25-35-induced neurotoxicity through estrogen receptor-dependent activation of PI3K/Akt pathways, inactivation of GSK-3β and activation of Nrf2/ARE/HO-1 pathways. Gypenoside XVII has protective effects to the cellular and rodent models of Alzheimer's disease by activating TFEB.
Gypsogenin
Catalog No: CFN91485
Gypsogenin shows antiangiogenic activity and the significant cytotoxicity against H460
Gyrophoric acid
Catalog No: CFN98919
Vulpinic and gyrophoric acids are known as ultraviolet filters for natural lichen populations, they can effectively prevent cytotoxic, apoptotic and cytoskeleton alterative activities of 2.5 J/cm(2) UVB in a dose-dependent manner, suggest that vulpinic and gyrophoric acids can be promising cosmetic ingredients to photo-protect human skin cells. Gyrophoric acid also has anti-proliferative/cytotoxic effect.
Halleridone
Catalog No: CFN91591
halleridone activated Nrf2-mediated HO-1 expression and inhibited Aβ1-42-overexpressed microglial BV-2 cell activation
Hamaudol
Catalog No: CFN95115
Hamaudol has analgesic and anti-inflammary activities, it showed inhibitory activity on COX-1 and COX-2 activities with values of 0.30, 0.57 mM, respectively.
Hannokinol
Catalog No: CFN96248
(+)-Hannokinol and MESO-hannokinol can significantly inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglial cells at concentrations ranging from 1 microM to 100 microM.
Previous
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
Next